Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study | Zendy

Ananda Basu | Zendy; Sona Veettil | Zendy; Roy B. Dyer | Zendy; Thomas A. Peyser | Zendy; Rita Basu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study

Author(s) -

Ananda Basu,

Sona Veettil,

Roy B. Dyer,

Thomas A. Peyser,

Rita Basu

Publication year - 2016

Publication title -

diabetes technology and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.142

H-Index - 88

eISSN - 1557-8593

pISSN - 1520-9156

DOI - 10.1089/dia.2015.0410

Subject(s) - medicine , acetaminophen , microdialysis , diabetes mellitus , anesthesia , insulin , pharmacology , endocrinology , central nervous system

Recent advances in accuracy and reliability of continuous glucose monitoring (CGM) devices have focused renewed interest on the use of such technology for therapeutic dosing of insulin without the need for independent confirmatory blood glucose meter measurements. An important issue that remains is the susceptibility of CGM devices to erroneous readings in the presence of common pharmacologic interferences. We report on a new method of assessing CGM sensor error to pharmacologic interferences using the example of oral administration of acetaminophen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research